Mangalam Drug Chem Share Price

Mangalam Drugs and Organics Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Under the Company's Fight Malaria Program, it supplies anti-malaria APIs worldwide. Its products include API, intermediates and specialty chemicals. Its API products include acyclovir, amodiaquine, artemether, artesunate, atazanavir sulfate, bisoprolol fumarate, chloroquine phosphate, furosemide and dolutegravir sodium. The Company's intermediates products include 4,6-Dichloro-5-Methoxy Pyrimidine; 4,7- dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base, and tenofovir disoproxil base. Its specialty chemical products include L (+)-menthol; 2,3-dihydrophthalazine-1,4-dione or phthalazine-1,4-dione, and 4-cynoethyl-2-methyl phenol. Its pipeline APIs (under development) include Ganaplacide (IH), Tafenoquine Succinate (IH) and Pretomanid (IH). Its pipeline APIs (developed for research and development) is Bictegravir Na (IH).As of 25 May 2026, Mangalam Drug Chem share price is ₹29.01. The stock opened at ₹30.59, compared to its previous close of ₹29.41. During today's trading session, Mangalam Drug Chem share price moved in the range of ₹29.01 to ₹30.59, with an average price of ₹29.80 for the day. Looking at its last 52-week, the stock has touched a low of ₹29.01 and a high of ₹30.59. On the performance front, Mangalam Drug Chem share price has declined by 19.77% over the last six months and is down 64.27% on a year-on-year basis.

The market capitalization of Mangalam Drug Chem is ₹47 Crs, with a P/E ratio of -1.1 and a dividend yield of 0.00%.